This approval would allow Glenmark Therapeutics Inc., USA to market the product in the US market and would further fortify its ophthalmic portfolio.
The partnership was formalized via a Memorandum of Understanding (MoU) inked on March 20, 2025.
BHEL was awarded the contract following an international competitive bidding process and is expected to complete the project in 54 months.
Top gainers in Sensex include Bajaj Finance, Larsen, NTPC, Kotak Mahindra.
On March 20, 2025, the company disclosed this in a regulatory filing, which was approved by its Finance Committee.
Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets
With year-to-date order inflows nearing ₹9,200 crore, the company continues to expand its project portfolio.
As part of its capacity expansion programs, the company saw multiple opportunities to improve efficiency and rationalise operations at different locations.
The Cumberland’s clientele will have greater flexibility in managing their finances, whether via phone, online, or in-branch.
The company informed the bourses that the record date for interim dividend has been fixed as March 26, 2025, as per SEBI regulations.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
